Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1375762 | Bioorganic & Medicinal Chemistry Letters | 2008 | 5 Pages |
Abstract
A lead benzamide, 3, was identified as a potent and low molecular weight histone deacetylase (HDAC) inhibitor. Optimization led to 16d, demonstrating an excellent balance of efficacy and non-efficacy properties, along with very desirable in vivo DMPK. The final compounds presented are >1000-fold more potent than the initial screen hit, an improvement in potency which was achieved with a concomitant significant improvement in all the main non-efficacy properties.
Graphical abstractThe synthesis of the HDAC inhibitor 16d is reported. (HDAC1 enzyme pIC50 7.46. A549a xenograft efficacy at 12.5 mg/kg.)Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
David M. Andrews, Elaine S.E. Stokes, Greg R. Carr, Zbigniew S. Matusiak, Craig A. Roberts, Michael J. Waring, Madeleine C. Brady, Christine M. Chresta, Simon J. East,